Women with pregnancy-induced hypertension (PIH) are at increased risk for preeclampsia, cesarean delivery, renal dysfunction, and placental abruption; associated risks to the fetus include intrauterine growth restriction, preterm delivery, low birth weight, and neonatal ICU admission. Ongoing monitoring for increased hypertension and proteinuria, consideration of expectant management or labor induction, and appropriate use of antihypertensive therapy are essential components in the management of women with PIH.
TO VIEW THIS AND OTHER CE/CME COURSES, CLICK HERE